Clinical Trials Browser

INDUSTRY × Colony-Stimulating Factors × Dermatologic × Clear all

NCT01368276 2015-12-18

An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Phase 3 Completed

31 enrolled 11 charts

Melanoma